News headlines about The Ensign Group (NASDAQ:ENSG) have been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. The Ensign Group earned a daily sentiment score of 0.11 on Accern’s scale. Accern also gave media coverage about the company an impact score of 46.2055888717035 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
ENSG has been the subject of several analyst reports. BidaskClub upgraded shares of The Ensign Group from a “buy” rating to a “strong-buy” rating in a report on Saturday. Zacks Investment Research upgraded shares of The Ensign Group from a “hold” rating to a “buy” rating and set a $29.00 price objective for the company in a report on Friday, February 16th. Royal Bank of Canada reiterated a “buy” rating on shares of The Ensign Group in a research report on Monday, February 12th. SunTrust Banks set a $29.00 target price on shares of The Ensign Group and gave the stock a “buy” rating in a research report on Friday, February 9th. Finally, Stifel Nicolaus set a $22.00 price objective on shares of The Ensign Group and gave the company a “hold” rating in a research report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $26.80.
Shares of The Ensign Group (ENSG) traded up $0.67 during midday trading on Wednesday, hitting $28.13. 300,586 shares of the company traded hands, compared to its average volume of 275,570. The stock has a market capitalization of $1,450.00, a P/E ratio of 33.49, a price-to-earnings-growth ratio of 1.10 and a beta of 0.63. The Ensign Group has a 12 month low of $16.50 and a 12 month high of $29.24. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.61.
In other The Ensign Group news, Director John G. Nackel sold 7,000 shares of the business’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $27.90, for a total value of $195,300.00. Following the completion of the transaction, the director now owns 84,232 shares of the company’s stock, valued at approximately $2,350,072.80. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Beverly B. Wittekind sold 9,664 shares of the business’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $23.60, for a total value of $228,070.40. Following the completion of the transaction, the vice president now directly owns 51,320 shares of the company’s stock, valued at approximately $1,211,152. The disclosure for this sale can be found here. In the last quarter, insiders sold 117,310 shares of company stock worth $2,930,044. 6.20% of the stock is currently owned by company insiders.
The Ensign Group Company Profile
The Ensign Group, Inc, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Texas, Utah, Washington and Wisconsin.
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.